Company Search:
Advanced Search
Sponsored Links
Galapagos NV Company Snapshot
Galapagos NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galapagos NV with three other miscellaneous service companies in Europe: Genmab A/S of Denmark (2018 sales of 3.03 billion Danish Kroner [US$447.05 million] of which 100% was Pharmaceticals), Bachem Holding AG of Switzerland (282.50 million Swiss Francs [US$283.35 million] of which 89% was Active Pharmaceutical Ingredients), and AddLife AB which is based in Sweden (2.48 billion Swedish Kronor [US$253.12 million] of which 58% was LabTech).

Sales Analysis. Galapagos NV reported sales of 317.85 million Euro (US$350.82 million) for the year ending December of 2018. This represents an increase of 103.9% versus 2017, when the company's sales were 155.92 million Euro. This was the third consecutive year of growth at Galapagos NV. Sales of R&d saw an increase of 135.6% in 2018, from 118.26 million Euro to 278.67 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Galapagos NV
  Stock Performance Chart for Galapagos NV
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 141.65
(Figures in Euro)
1 Week 2.6%   13 Weeks -3.5%  
4 Weeks 10.5%   52 Weeks 64.9%  
Galapagos NV Key Data:
  Ticker: GLPG Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 317,845,000
(Year Ending Jan 2019).
Employees: 725
  Currency: Euro Market Cap: 7,765,692,257
  Fiscal Yr Ends: December Shares Outstanding: 54,823,101
  Share Type: Action Ordinaries Closely Held Shares: 6,760,701
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.